Bojan Polić

Bojan Polić


Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 March 2015 in Nature Immunology
Verified
Journal Article
Closed access
FWFelix Martinus Wensveen
Felix Martinus Wensveen
VJVedrana Jelenčić
Vedrana Jelenčić
SVSonja Valentić
Sonja Valentić
MŠMarko Šestan
Marko Šestan
TWTamara Turk Wensveen
Tamara Turk Wensveen
BPBojan Polić
Bojan Polić

2 February 2016 in Aging
Verified
Journal Article
Open access
ASAdi Sagiv
Adi Sagiv
DBDominick G. A. Burton
Dominick G. A. Burton
ZMZhana Moshayev
Zhana Moshayev
EVEzra Vadai
Ezra Vadai
FWFelix Martinus Wensveen
Felix Martinus Wensveen
VKValery Krizhanovsky
Valery Krizhanovsky
Cellular senescence is a stress response mechanism that limits tumorigenesis and tissue damage. Induction of cellular senescence commonly coincides with an immunogenic phenotype that promotes self-elimination by components of the immune system, thereby facilitating tumor suppression and limiting excess fibrosis during wound repair. The mechanisms by which senescent cells regulate their immune surveillance are not completely understood. Here we show that ligands of an activating Natural Killer (NK) cell receptor (NKG2D), MICA and ULBP2 are consistently up-regulated following induction of replicative senescence, oncogene-induced senescence and DNA damage - induced senescence. MICA and ULBP2 proteins are necessary for efficient NK-mediated cytotoxicity towards senescent fibroblasts. The mechanisms regulating the initial expression of NKG2D ligands in senescent cells are dependent on a DNA damage response, whilst continuous expression of these ligands is regulated by the ERK signaling pathway. In liver fibrosis, the accumulation of senescent activated stellate cells is increased in mice lacking NKG2D receptor leading to increased fibrosis. Overall, our results provide new insights into the mechanisms regulating the expression of immune ligands in senescent cells and reveal the importance of NKG2D receptor-ligand interaction in protecting against liver fibrosis.

8 March 2018 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
FWFelix Martinus Wensveen
Felix Martinus Wensveen
VJVedrana Jelenčić
Vedrana Jelenčić
BPBojan Polić
Bojan Polić
NKG2D is an activating receptor that is mostly expressed on cells of the cytotoxic arm of the immune system. Ligands of NKG2D are normally of low abundance, but can be induced in virtually any cell in response to stressors, such as infection and oncogenic transformation. Engagement of NKG2D stimulates the production of cytokines and cytotoxic molecules and traditionally this receptor is, therefore, viewed as a molecule that mediates direct responses against cellular threats. However, accumulating evidence indicates that this classical view is too narrow. During NK cell development, engagement of NKG2D has a long-term impact on the expression of NK cell receptors and their responsiveness to extracellular cues, suggesting a role in NK cell education. Upon chronic NKG2D engagement, both NK and T cells show reduced responsiveness of a number of activating receptors, demonstrating a role of NKG2D in induction of peripheral tolerance. The image that emerges is that NKG2D can mediate both inhibitory and activating signals, which depends on the intensity and duration of ligand engagement. In this review, we provide an overview of the impact of NKG2D stimulation during hematopoietic development and during acute and chronic stimulation in the periphery on responsiveness of other receptors than NKG2D. We propose that NKG2D interprets the context of the immunological environment through detection of cellular cues and in response sets the appropriate activation threshold for a large number of immune receptors. This perspective is of particular importance for future therapies that aim to exploit NKG2D signaling to fight tumors or infection.

19 August 2015 in European Journal of Immunology
Verified
Journal Article
Closed access
PDF file
FWFelix Martinus Wensveen
Felix Martinus Wensveen
SVSonja Valentić
Sonja Valentić
MŠMarko Šestan
Marko Šestan
TWTamara Turk Wensveen
Tamara Turk Wensveen
BPBojan Polić
Bojan Polić

21 September 1998 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
BPBojan Polić
Bojan Polić
HHHartmut Hengel
Hartmut Hengel
AKAstrid Krmpotić
Astrid Krmpotić
JTJoanne Trgovcich
Joanne Trgovcich
IPIvica Pavić
Ivica Pavić
UKUlrich H. Koszinowski
Ulrich H. Koszinowski
Reactivation from latent cytomegalovirus (CMV) infection is often associated with conditions of immunosuppression and can result in fatal disease. Whether the maintenance of systemic CMV latency is mainly governed by factors of the infected cell or by immune control functions is unknown. Likewise, the putative immune control mechanisms which could prevent the induction and spread of recurrent CMV infection are not clearly identified. We took advantage of latently infected B cell–deficient mice and a sensitive method for virus detection to study CMV reactivation after ablation of lymphocyte subsets. A crucial role of both T lymphocytes and natural killer (NK) cells was demonstrated. Within 5 d after depletion of lymphocytes, productive infection occurred in 50% of mice, and 14 d later 100% of mice exhibited recurrent infection. A hierarchy of immune control functions of CD8+, NK, and CD4+ cells was established. Reactivation was rare if only one of the lymphocyte subsets was depleted, but was evident after removal of a further subset, indicating a functional redundancy of control mechanisms. The salivary glands were identified as the site of most rapid virus shedding, followed by the detection of recurrent virus in the lungs, and eventually in the spleen. Our findings document a previously unknown propensity of latent CMV genomes to enter productive infection immediately and with a high frequency after immune cell depletion. The data indicate that only the sustained cellular immune control prevents CMV replication and restricts the viral genome to a systemic state of latency.

1 November 2014 in Immunity
Verified
Journal Article
Closed access
JVJ. Christoph Vahl
J. Christoph Vahl
CDChristoph Drees
Christoph Drees
KHKlaus Heger
Klaus Heger
SHSylvia Heink
Sylvia Heink
JFJulius C. Fischer
Julius C. Fischer
MSMarc Schmidt-Supprian
Marc Schmidt-Supprian